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ess: mohamed.gouda@dSummary In patients with poliomyelitis, respiratory failure requiring ventilatory
support may occur during the acute illness. Some patients continue to require long-
term nocturnal ventilatory support; others are weaned but subsequently require
support because of a late deterioration in ventilatory function.
Objectives: To assess the sensitivity of sniff nasal inspiratory pressure (SNIP) to
post-poliomyelitis respiratory muscle weakness and to assess the relationship
between the respiratory muscle strength and the need for ventilatory support in
patients with previous poliomyelitis (post-polio patients).
Methods: Respiratory muscle strength was measured in 50 post-polio patients. Tests
included forced vital capacity (FVC), maximum inspiratory and expiratory pressures
(MIP and MEP), and SNIP.
Results: Twenty-one patients used non-invasive nocturnal ventilatory support (NIV
group) compared to 29 on no support (non-NIV group). The percentage predicted FVC
was significantly lower in the NIV group compared to the non-NIV group (P ¼ 0:01).
Similarly, the percentage predicted MIP was significantly lower in NIV group
(P ¼ 0:007). Low SNIP values (both absolute value and percentage predicted) were
associated with the need for ventilatory support (Po0:001). Of the patients
requiring no support, those who had been ventilated during the acute episode of
poliomyelitis had a significantly lower SNIP than those who had never been
ventilated (P ¼ 0:04).
Conclusions: Post-polio patients who are currently on nocturnal ventilation
have significantly lower FVC, MIP and SNIP compared to currently non-ventilated
patients. Non-ventilated patients who were ventilated during the acute episode
of poliomyelitis have significantly weaker respiratory muscle strength than patients
who were never ventilated. This study indicates that SNIP is more sensitive toElsevier Ltd. All rights reserved.
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octors.net.uk (M.G. Soliman).
ARTICLE IN PRESS
M.G. Soliman et al.1218post-polio respiratory muscle weakness than other non-invasive tests. Thus
measurement of SNIP is a valuable tool for monitoring the progression of respiratory
muscle weakness due to previous poliomyelitis and this can be applied to other
neuromuscular disorders.
& 2005 Elsevier Ltd. All rights reserved.Introduction
Patients with paralytic poliomyelitis may require
respiratory support during the acute illness. A
proportion of these patients will continue to need
long-term ventilation and others, who have been
weaned, may require the reintroduction of support
after a prolonged latent period. A small proportion
of patients may need ventilatory support after
many years even if they were not ventilated during
the acute illness.1 There is no reliable method for
predicting those patients who will develop pro-
gressive respiratory insufficiency requiring ventila-
tory support many years after the acute illness.
Late functional deterioration following acute
poliomyelitis has been reported after a prolonged
period of stability.2 There has been a great deal of
interest over the past 15 years in the pathophysiol-
ogy of this disorder, which has been termed
’ ’
The
Post-polio Syndrome’’.3,4 The commonest clinical
features of post-polio syndrome are muscle weak-
ness, muscle atrophy, pain, fatigue, joint failure
and sleep apnoea.5 Respiratory failure may develop
because of respiratory muscle weakness. Bulbar
and brain stem involvement may contribute to the
need for ventilation in the acute illness. In later
years, progressive scoliosis, acute infections, obe-
sity or pulmonary disease may precipitate the need
for ventilatory support.6
Assessment of respiratory muscle weakness in
patients with neuromuscular disorders is difficult
because lung volumes may still be near normal in
the presence of significant muscle weakness;
furthermore, testing lung volumes is difficult to
perform as it depends on patient’s co-operation
and, in some conditions, full volitional control may
be impaired.
Respiratory muscle strength is usually assessed by
MIP and MEP,7 but these tests may prove difficult for
some patients to perform, and low values may be
due to incomplete effort or air leaks if there is
bulbar or facial muscle weakness.8 Respiratory
muscle strength is often better reflected by
oesophageal pressure during maximal sniffs (sniff
Poes) than by MIP.9 However, sniff Poes is an invasive
method requiring an oesophageal balloon catheter
system, which limits its clinical usefulness.
The maximal sniff nasal inspiratory pressure
(SNIP) is a non-invasive measure of respiratorymuscle strength.10–12 It has been shown to corre-
late closely with the sniff Poes in normal subjects
and in patients with neuromuscular and skeletal
disorders.10,12 In a recent study of 16 patients with
Amyotrophic Lateral Sclerosis,13 SNIP was shown to
be more sensitive than vital capacity (VC) to small
changes in muscle strength, and to decline in a
linear fashion as the disease progresses. In contrast
to MIP and MEP, the SNIP can be performed without
difficulty late in the course of the disease and in
the presence of orofacial weakness.
The aim of the current study was to elucidate the
relationship between respiratory muscle strength
and the current or previous need for ventilatory
assistance among post-polio patients. Furthermore,
to compare the sensitivity of the SNIP with that
of more classical tests of respiratory functions
such as maximal respiratory pressures (MIP and
MEP) and FVC.Patients and methods
The Lane-Fox Respiratory Unit is responsible for the
care of more than 1000 polio survivors who live
throughout the UK.
Fifty post-polio patients were seen consecutively
in the Lane-Fox Unit as outpatients. Patients were
divided into the following groups:1. Those receiving nocturnal non-invasive ventila-
tion (NIV): this group consisted of 21 patients; 13
of whom had been ventilated during their acute
illness.2. Non-ventilated patients (non-NIV): this group
included 29 patients, of whom 13 had been
ventilated during their acute illness.
Bodyweight was measured and body mass index
(BMI) was calculated as (body weight/arm span2).14
Arm span was used instead of height due to
presence of skeletal deformities. Patients received
a detailed preliminary explanation and were
vigorously coached during the test manoeuvres.
FVC was measured by Vitalograph-Compact II
(Vitalograph Medical Instruments, Buckingham,
UK). The device was calibrated before each
individual study. Reference values proposed by
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inspiratory pressure (MIP) and maximal expiratory
pressure (MEP) were measured in the sitting
position using a standard flanged mouthpiece
connected to a mouth pressure meter (Precision
Medical limited, N.Yorks). MIP was measured from
the residual volume (RV) after maximal expiration,
and MEP was measured from the total lung capacity
(TLC) after maximal inspiration, with a nose clip in
place. Each effort was separated by 30–60 seconds
of rest. Five technically acceptable recordings
were obtained for each manoeuvre. The SNIP was
measured through a well-fitting flanged soft cathe-
ter fitted into one nostril during a sniff performed
via the contralateral nostril.16 Absence of leak was
ascertained by occluding the contralateral nostril
during an inspiratory effort. The nasal catheter
was connected to a DPT 350 Pressure Transducer
(Deva Medical Electronics LTD) through a polythene
catheter, then to a personal computer running
SPIKE II software (Cambridge Electronic Design)
for recording. The best of at least ten sniffs (or
until there was no further increase in SNIP) was
used for analysis. This number was previously
established as easy to perform and adequate for
obtaining a maximal value.16 Patients were asked
to perform short sharp sniffs from functional
residual capacity (FRC). Two or four normal breaths
separated successive sniff manoeuvres. The more
patent nostril was chosen for the manoeuvre.
The criteria used to select sniffs suitable for
analysis were: A pressure tracing showing a smooth upstroke
and a sharp peak. A sniff performed from FRC.
 Time to peak less than 300ms.The largest change in pressure was used for
analysis. Reference values of SNIP, MIP, and MEP for
adults were used for our study group.9,15,16
The Local Ethics Committee of the Guy’s and St
Thomas’s Hospital Trust approved the study proto-
col and all patients provided informed consent.
Data analysis: Absolute values of measurements
for MIP, MEP, FVC, and SNIP were recorded and the
percentage predicted values were calculated from
normative data. Data was grouped according to
whether or not patients were currently or pre-
viously ventilated. Different groups were compared
using t-test. Linear regression analysis was used
to compare SNIP, FVC, and respiratory pressures.
A value of Po0:05 was considered significant.
Unless otherwise stated, values are given as
mean7SD (range).Results
Clinical: Table 1 demonstrates the clinical char-
acteristics of the whole study group. We divided
patients into two groups based on whether or not
they are currently ventilated. There were no
significant differences as regards age, years post
polio, BMI, sex, partial pressure of oxygen (PO2) or
partial pressure of carbon dioxide (PCO2). In the
non-NIV group, some patients had abnormally
high PCO2 (5 patients), or abnormally low PO2
(10 patients).(A) Currently ventilated (NIV) versus currently
non-ventilated (non-NIV) patients (Table 2):
The percentage predicted FVC was significantly
lower in the NIV group compared to the non-NIV
group (P ¼ 0:01). The percentage predicted
SNIP was also significantly lower in the NIV
patients (Po0:001). The percentage predicted
MIP showed a statistically significant difference
between both groups (P ¼ 0:007), while there
were non-significant differences in the percen-
tage MEP or PaCO2 between both groups.(B) Patients not presently receiving ventilatory
support (Non-NIV) patients (Table 3): This
group is divided into two subgroups according
to the need for ventilation during acute polio.
The percentage predicted SNIP was significantly
lower in the subgroup that received ventilatory
support during the acute illness (P ¼ 0:04).
However, there were no statistically significant
differences between both subgroups as regards
MIP, MEP, and FVC. When considered individu-
ally, both subgroups showed a significantly
higher percentage predicted SNIP measure-
ments than the NIV group (P ¼ 0:002 and
Po0:001).(C) Patients presently receiving ventilatory sup-
port (NIV group) (Table 4): This group was also
divided into two subgroups according to the
need of ventilation during acute illness. There
were no significant differences between both
groups as regards FVC, SNIP, MIP, MEP and
PaCO2.(D) Patients who received ventilatory support
during the acute illness (Table 5): This group
of patients, who received ventilatory support
during the acute polio, was studied separately
and was subdivided according to whether or
not patients are currently receiving NIV. Cur-
rently ventilated patients have a statistically
significant lower percentage predicted
SNIP (P ¼ 0:006) than currently non-ventilated
ones. However, there were non-significant
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Table 2 Respiratory muscle assessment in currently NIV/non NIV patients.
Measurement of respiratory
muscle strength
Currently ventilated patients
(NIV, n ¼ 21)
Currently non-ventilated
patients (non-NIV, n ¼ 29)
P value
% Predicted FVC 29.9725.6 53.6739.9 0.01
%Predicted SNIP 29.9713.6 65.6723.8 o0.001
% Predicted MIP 36.3716.36 57.2732.5 0.007
% Predicted MEP 43.2726.2 53723.3 NS
PaCO2 43.477.4 40.779.8 NS
Table 1 Clinical features of 50 post-polio patients.
All Currently ventilated Currently non-ventilated P value
Number 50 21 29 NS
(Females) (26) (7) (19)
Age 57.678.9 59.478.9 56.378.1 NS
(44–75) (44–74) (45–75)
Years post-polio 49.578 49.678.8 49.977.8 NS
(39–73) (39–73) (40–71)
Weight (kg) 63.1714.6 65.4714.3 61.4714.9 NS
(32–98) (32–95) (41–98)
Arm span (m) 1.670.13 1.6270.13 1.5870.13 NS
(1.2–1.92) (1.45–1.92) (1.87–1.2)
BMI (kg/m2) 24.875.2 24.177.8 24.375.6 NS
(11.8–36) (11.8–33.9) (16.5–36)
%Patients ventilated during acute polio 52% 62% 45% NS
PO2 (N ¼ 80290) (mmHg) 82712.6 78.1715.1 84.979.8 NS
(57–116) (56.5–116) (61.9–110)
PCO2 (N ¼ 38247) (mmHg) 41.977 43.477.4 40.779.8 NS
(28–60) (30.4–60) (28–56.8)
M.G. Soliman et al.1220differences between both subgroups as regards
FVC, MIP, MEP and PaCO2.In post-polio patients, we observed that FVC
correlates with both SNIP and MIP, but more closely
with SNIP (Table 6). Fifteen out of the 50 patients
managed to perform a VC480% of the predicted,
nine patients out of these 15 had managed a
SNIP480%, and only three patients managed both
SNIP and MIP480%.
The mean SNIP for the whole study group was
45.6724.3 cmH2O, corresponding to 50.6726.8%
predicted. The mean MIP was 42724 cmH2O,
corresponding to 48.4729.9% predicted. Absolute
SNIP was higher than MIP in 34 of the 50 post-polio
patients (Po0:001).Discussion
Although poliomyelitis is considered to be an acute
monophasic illness many workers who have been
involved in the long-term care and rehabilitation of
polio patients have noted a late deterioration in
their neurological, musculoskeletal and respiratory
functions.17 Previous reports have shown that late
respiratory insufficiency is associated with noctur-
nal hypoventilation due to respiratory muscle
weakness, progressive scoliosis and skeletal defor-
mities, particularly in those who had received
ventilatory support during the acute illness.1
Using the SNIP measurement, we have demon-
strated significant inspiratory muscle weakness in
those patients with old polio who now require
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Table 3 Respiratory muscle assessment in currently non-NIV patients.
Measurement of respiratory
muscle strength
Not ventilated during the
acute polio (N ¼ 16)
Ventilated during the acute
polio (N ¼ 13)
P value
% Predicted FVC 54.15742.4 53.6738.5 NS
% Predicted SNIP 73.7723 55.8721.7 0.04
% Predicted MIP 53.3729.2 62.1737.7 NS
% Predicted MEP 57.5725.6 47.4719.3 NS
Table 4 Respiratory muscle assessment in currently ventilated group.
Respiratory muscle strength Currently ventilated and
ventilated during acute polio
Currently ventilated and not
ventilated during acute polio
P value
% Predicted FVC 28.6724.1 32.1729.5 NS
% Predicted SNIP 25.8714.2 36.5710.4 NS
% Predicted MIP 35.8721.4 37718.7 NS
% Predicted MEP 42.1727.3 45725.95 NS
PaCO2 44.377.96 41.976.8 NS
Table 5 Respiratory muscle assessment of patients who received ventilator support during acute polio illness.
Respiratory muscle strength Currently ventilated
(N ¼ 13)
Currently not ventilated
(N ¼ 13)
P value
% Predicted FVC 40.8733.8 46.8739.4 NS
% Predicted SNIP 40.8723.6 61.3726.4 0.0059
% Predicted MIP 48.9732.9 47.9726.9 NS
% Predicted MEP 44.7723.3 53.3725.9 NS
PaCO2 42.778.6 40.974.9 NS
Table 6 The relationship between respiratory
pressures and vital capacity.
Test Post-polio patients
(N ¼ 50)
SNIP versus MIP R ¼ 0:38
Po0:0001
SNIP versus VC R ¼ 0:36
Po0:0001
MIP versus VC R ¼ 0:22
P ¼ 0:0007
Non-invasive assessment of respiratory muscle strength in patients with previous poliomyelitis 1221nocturnal ventilatory support compared to those
who do not. FVC and MIP were also significantly
reduced in patients requiring NIV although this was
not as highly significant as SNIP. Furthermore,
patients who are presently non-ventilated had a
significantly lower SNIP if they were ventilatedduring acute polio compared to those who were
never ventilated. This is in keeping with the earlier
findings of Howard et al.1 who noted that 38% of a
selected population of post-polio patients with late
functional deterioration required ventilatory sup-
port with a mean latent period of 23 years after
having received support during acute illness and
been subsequently weaned.
In the present study, we demonstrated a correla-
tion between SNIP and the MIP. Stefanutti et al.10
demonstrated a similar finding in their study to
assess the usefulness of SNIP in 116 patients with
neuromuscular and skeletal disorders. However,
other studies in healthy subjects have suggested
that the correlation between MIP and SNIP is
poor.16,18 Certainly, important differences exist
between both tests. Firstly, SNIP is performed
during a ballistic effort, whereas MIP requires a
sustained effort. The sniff is an easy and natural
manoeuvre, which may allow subjects to activate
their inspiratory muscles more completely than MIP
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assessed in the study group, most patients reported
that the sniff manoeuvre was easier to perform
than MIP manoeuvre. Secondly, the sniff nasal and
MIP manoeuvres are not equivalent because the
pattern of muscle activation is known to differ
between both manoeuvres.19 In spite of that, some
patients in the present study group were still able
to manage higher MIP values than SNIP.
The SNIP measure is readily available, easy to
perform, non-invasive, and more sensitive to post
polio respiratory muscle weakness than FVC.
Normal values obtained with this simple test rule
out clinically significant inspiratory muscle weak-
ness. SNIP measurement should become a routine
part of the assessment of patients with neuromus-
cular and skeletal disorders, both to assess the
presence of respiratory muscle weakness and to
undertake sequential monitoring of patients who
are at risk of developing respiratory insufficiency.References
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